Results 101 to 110 of about 25,773 (228)
Introduction: Treatment strategies for chronic hepatitis B (CHB) using either interferon or Lamivudine can achieve sustained response in 30-40 % in HBeAg positive CHB.
Deepak N. Amarapurkar, Nikhil D. Patel
doaj +1 more source
ABSTRACT To address data gaps around metabolic liver disease in Africa, within the Hepatitis B in Africa Collaborative Network (HEPSANET), we evaluated participants with chronic hepatitis B virus infection (CHB) for steatotic liver disease (SLD) using transient elastography with controlled attenuation parameter (CAP).
Freeman W. Chabala +52 more
wiley +1 more source
Factors predicting retreatment for HBeAg-negative patients.
Factors predicting retreatment for HBeAg-negative patients.
Tsung-Hui Hu (349887) +5 more
core +1 more source
ABSTRACT Background and Aims Chronic hepatitis B (CHB) remains a major global health burden. Current therapies rarely achieve a functional cure due to low rates of HBsAg clearance, the persistence of the viral replication template—covalently closed circular DNA (cccDNA)—and the need for lifelong treatment.
Yuming Guo +22 more
wiley +1 more source
HBeAg status in the four age cohorts.
HBeAg status in the four age cohorts.
Leland Yee (706287) +7 more
core +1 more source
Journal of Viral Hepatitis, Volume 33, Issue 12, December 2026.
Erwan Vo‐Quang +6 more
wiley +1 more source
Immunological characteristics of HBeAg-negative HCC patients.
Immunological characteristics of HBeAg-negative HCC patients.
Meng Fang (473455) +7 more
core +1 more source
Factors predicting retreatment for HBeAg-positive patients.
Factors predicting retreatment for HBeAg-positive patients.
Tsung-Hui Hu (349887) +5 more
core +1 more source
Increasing hepatitis B viral load is associated with risk of signi¢cant liver ¢brosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B [PDF]
Background/aims: To evaluate the association between demographical features, serum ALT and HBV DNA and the prevalence of significant fibrosis and inflammation on liver biopsy in patients with chronic hepatitis B. Methods: In this cross-sectional study of
Paul V Desmond +8 more
core
To identify the prevalence of hepatitis B e antigen (HBeAg) and to assess the association of hepatitis B virus (HBV) core promoter mutations and viral load in Indonesian patients.Sixty-four patients with chronic hepatitis, 65 with liver cirrhosis and 50 with hepatocellular carcinoma were included in this study.
Andi, Utama +16 more
openaire +2 more sources

